Massachusetts
Biogen shares rise on sales of groundbreaking Alzheimer's drug Leqembi
Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher than expected sales of its groundbreaking Alzheimer’s drug Leqembi. Read more...
Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher than expected sales of its groundbreaking Alzhei… [+1465 chars]
Related
Share this page
Guest Posts by Easy Branches